Payments to Acquire Property, Plant, and Equipment of UroGen Pharma Ltd. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
UroGen Pharma Ltd. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • UroGen Pharma Ltd. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $44,000.
  • UroGen Pharma Ltd. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $289,000, a 2% decline from 2024.
  • UroGen Pharma Ltd. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $295,000, a 52% increase from 2023.
  • UroGen Pharma Ltd. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $194,000, a 24% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

UroGen Pharma Ltd. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $289,000 -$6,000 -2% 01 Jan 2025 31 Dec 2025 10-K 02 Mar 2026 2025 FY
2024 $295,000 +$101,000 +52% 01 Jan 2024 31 Dec 2024 10-K 02 Mar 2026 2025 FY
2023 $194,000 -$60,000 -24% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2025 2024 FY
2022 $254,000 -$498,000 -66% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $752,000 -$463,000 -38% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $1,215,000 +$890,000 +274% 01 Jan 2020 31 Dec 2020 10-K 21 Mar 2022 2021 FY
2019 $325,000 -$235,000 -42% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
2018 $560,000 +$289,000 +107% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2020 2019 FY
2017 $271,000 -$424,000 -61% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $695,000 +$394,000 +131% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $301,000 01 Jan 2015 31 Dec 2015 20-F 15 Mar 2018 2017 FY

UroGen Pharma Ltd. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $44,000 +$44,000 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $0 -$23,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $23,000 -$2,000 -8% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $25,000 -$262,000 -91% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $287,000 +$191,000 +199% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $96,000 +$52,000 +118% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $44,000 -$28,000 -39% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $72,000 -$6,000 -7.7% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $78,000 01 Jan 2017 31 Mar 2017 6-K 15 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.